Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 8181152)

Published in Circulation on May 01, 1994

Authors

Z Yang1, U Arnet, E Bauer, L von Segesser, R Siebenmann, M Turina, T F Lüscher

Author Affiliations

1: Department of Medicine, University Hospitals Basel, Switzerland.

Articles by these authors

Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem (1999) 6.59

Outcome of survivors of accidental deep hypothermia and circulatory arrest treated with extracorporeal blood warming. N Engl J Med (1997) 5.00

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation (1995) 4.59

Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood (2000) 3.60

Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation (2001) 3.38

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28

A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A (2000) 3.28

Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med (2000) 3.09

Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A (1999) 2.71

Acute heart transplant rejection due to Saint John's wort. Lancet (2000) 2.71

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation (1994) 2.69

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest (1990) 2.61

Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med (1998) 2.58

High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation (1997) 2.51

Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass. Lancet (1991) 2.50

Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension (1986) 2.30

Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation (1998) 2.27

Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation (1996) 2.05

Gamma/delta T-cell stimulation by pamidronate. N Engl J Med (1999) 2.04

Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation (1990) 1.98

Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation (1991) 1.96

Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation (2000) 1.93

Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res (2000) 1.84

8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med (2001) 1.80

Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med (1988) 1.79

Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J (2004) 1.76

Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation (1997) 1.67

[True aneurysm of the ascending aorta in HIV disease]. Schweiz Med Wochenschr (1994) 1.63

Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest (1998) 1.62

[Interrupted aortic arch: fortuitous diagnosis in a 72-year-old female patient with severe aortic insufficiency]. Schweiz Med Wochenschr (1995) 1.61

Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol (1991) 1.58

Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol (1998) 1.58

Monitoring gene therapy with reporter gene imaging. Semin Nucl Med (2001) 1.56

Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery? Eur J Cardiothorac Surg (2000) 1.55

Diagnostic and therapeutic strategy in malignant pleural mesothelioma. Eur J Cardiothorac Surg (1991) 1.55

Pre- and postoperative findings in patients with endomyocardial fibrosis. Br Heart J (1978) 1.55

Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol (1997) 1.51

Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest (1996) 1.50

Congenital aortopulumonary window: diagnosis, surgical technique and long-term results. Eur J Cardiothorac Surg (1997) 1.49

Cardiac surgery for Kartagener syndrome. Pediatr Cardiol (1997) 1.48

Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension (1990) 1.47

Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron (1986) 1.47

Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation (1989) 1.47

Predictors of long-term survival after valve replacement for chronic aortic regurgitation; is M-mode echocardiography sufficient? Eur Heart J (2001) 1.47

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A (2000) 1.47

Endothelin. Key to coronary vasospasm? Circulation (1991) 1.46

Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart (2007) 1.45

Perioperative antibiotic prophylaxis in cardiovascular surgery: a prospective randomized comparative trial of cefazolin versus ceftriaxone. World J Surg (1990) 1.45

Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg (2000) 1.45

Aging, serum estradiol levels, and pregnancy differentially affect vascular reactivity of the rat uterine artery. J Soc Gynecol Investig (2000) 1.44

Futility of pericardiectomy for postirradiation constrictive pericarditis? Ann Thorac Surg (1990) 1.44

Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol (2000) 1.43

Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation (1990) 1.42

ICD implantation with and without combined myocardial revascularisation--incidence of ICD therapy and late survival. Thorac Cardiovasc Surg (2002) 1.42

Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg (2001) 1.41

Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension (1997) 1.41

Indications for pericardial glutaraldehyde-preserved xenograft in repair of congenital heart disease. J Card Surg (1989) 1.40

Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.40

[Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions]. Schweiz Med Wochenschr (1997) 1.39

Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc Res (1999) 1.39

[Catheter-induced dissection of the right coronary ostium and aortic root]. Z Kardiol (1999) 1.39

Infected endocardial pacemaker electrodes: successful open intracardiac removal. Pacing Clin Electrophysiol (1993) 1.38

Brief report: reuse of a transplanted heart. N Engl J Med (1993) 1.38

Echo-free perfused spaces: a current postoperative finding after homograft replacement of the aortic valve. J Thorac Cardiovasc Surg (1994) 1.38

Prognosis of medically treated patients referred for cardiac transplantation. Int J Cardiol (1998) 1.38

New approach to patency and flow assessment after left internal thoracic artery hypoperfusion syndrome with additional saphenous vein graft to the left anterior descending artery with phase-contrast magnetic resonance angiography. J Thorac Cardiovasc Surg (1997) 1.38

Propionibacterium acnes as a cause of aggressive aortic valve endocarditis and importance of tissue grinding: case report and review. J Clin Microbiol (1994) 1.38

Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res (1990) 1.37

Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res (2001) 1.36

Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation (2000) 1.35

Risk of injury through snowboarding. J Trauma (2000) 1.35

Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest (1995) 1.34

Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension (1995) 1.34

Maximizing the reliability of genomic selection by optimizing the calibration set of reference individuals: comparison of methods in two diverse groups of maize inbreds (Zea mays L.). Genetics (2012) 1.34

Long-term outlook after atrial correction of transposition of great arteries. J Thorac Cardiovasc Surg (1988) 1.33

The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol (1995) 1.32

Continuous versus bolus thermodilution cardiac output measurements--a comparative study. Crit Care Med (1995) 1.32

Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension (1987) 1.30

[Heart tumors: incidence, distribution, diagnosis. Exemplified by 20,305 echocardiographies]. Schweiz Med Wochenschr (1991) 1.28

Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol (1990) 1.28

Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation (1995) 1.27

Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (1998) 1.26

Compliance in hypertension: facts and concepts. J Hypertens Suppl (1985) 1.25

Dealing with dilated ascending aorta during aortic valve replacement: advantages of conservative surgical approach. Eur J Cardiothorac Surg (1991) 1.25